Details for New Drug Application (NDA): 071839
✉ Email this page to a colleague
NDA 071839 describes MINOXIDIL, which is a drug marketed by Perrigo Pharma Intl, Endo Operations, Royce Labs, Sun Pharm Industries, Usl Pharma, Watson Labs, Aurobindo Pharma, P And L, Taro, Apotex Inc, Aurobindo Pharma Ltd, Bausch And Lomb, Copley Pharm, Hikma, L Perrigo Co, Sight Pharms, Teva, Avacor Prods, Perrigo, and Perrigo New York, and is included in twenty-eight NDAs. It is available from twenty-nine suppliers. Additional details are available on the MINOXIDIL profile page.
The generic ingredient in MINOXIDIL is minoxidil. There are eight drug master file entries for this compound. Eighty-six suppliers are listed for this compound. Additional details are available on the minoxidil profile page.
The generic ingredient in MINOXIDIL is minoxidil. There are eight drug master file entries for this compound. Eighty-six suppliers are listed for this compound. Additional details are available on the minoxidil profile page.
Summary for 071839
| Tradename: | MINOXIDIL |
| Applicant: | Endo Operations |
| Ingredient: | minoxidil |
| Patents: | 0 |
Pharmacology for NDA: 071839
| Physiological Effect | Arteriolar Vasodilation |
Medical Subject Heading (MeSH) Categories for 071839
Suppliers and Packaging for NDA: 071839
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| MINOXIDIL | minoxidil | TABLET;ORAL | 071839 | ANDA | Endo USA, Inc. | 49884-257 | 49884-257-01 | 100 TABLET in 1 BOTTLE (49884-257-01) |
| MINOXIDIL | minoxidil | TABLET;ORAL | 071839 | ANDA | Endo USA, Inc. | 49884-257 | 49884-257-05 | 500 TABLET in 1 BOTTLE (49884-257-05) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 10MG | ||||
| Approval Date: | Nov 14, 1988 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
